Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

High-throughput assays for promiscuous inhibitors

  • Brian Y. Feng
  • , Anang Shelat
  • , Thompson N. Doman
  • , R. Kip Guy
  • , Brian K. Shoichet

Producción científica: Articlerevisión exhaustiva

323 Citas (SciVal)

Resumen

High-throughput screening (HTS) searches large libraries of chemical compounds for those that can modulate the activity of a particular biological target; it is the dominant technique used in early-stage drug discovery. A key problem in HTS is the prevalence of nonspecific or ‘promiscuous’ inhibitors. These molecules have peculiar properties, act on unrelated targets and can dominate the results from screening campaigns. Several explanations have been proposed to account for promiscuous inhibitors, including chemical reactivity1, 2, interference in assay read-out2, highmolecular flexibility3 and hydrophobicity2, 4. The diversity of these models reflects the apparently unrelated molecules whose behaviors they seek to explain. However, a single mechanism may explain the effects of many promiscuous inhibitors: some organic molecules form large colloid-like aggregates that sequester and thereby inhibit enzymes5. Hits from HTS, leads for drug discovery and even several drugs appear to act through this mechanism at micromolar concentrations5-9. Here, we report two rapid assays for detecting promiscuous aggregates that we tested against 1, 030 ‘drug-like’ molecules. The results from these assays were used to test two preliminary computational models of this phenomenon and as benchmarks to develop new models.

Idioma originalEnglish
Páginas (desde-hasta)146-148
Número de páginas3
PublicaciónNature Chemical Biology
Volumen1
N.º3
DOI
EstadoPublished - ago 2005

Nota bibliográfica

Funding Information:
Supported by GM71630, the QB3 fund and the Burroughs-Wellcome Fund (A.S.). We thank J. Weisman and members of the Shoichet laboratory for reading this manuscript.

Financiación

Supported by GM71630, the QB3 fund and the Burroughs-Wellcome Fund (A.S.). We thank J. Weisman and members of the Shoichet laboratory for reading this manuscript.

FinanciadoresNúmero del financiador
Burroughs Wellcome Fund
National Institute of General Medical SciencesR01GM071630

    ASJC Scopus subject areas

    • Molecular Biology
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'High-throughput assays for promiscuous inhibitors'. En conjunto forman una huella única.

    Citar esto